Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,120 recruiting studies in this area right now.
By phase
- Not applicable9,489
- Phase 24,393
- Phase 12,659
- Phase 1/Phase 21,650
- Phase 31,388
- Phase 2/Phase 3281
- Phase 4260
Top conditions
- Breast Cancer1,192
- Prostate Cancer645
- Cancer634
- Colorectal Cancer479
- Lung Cancer416
- Ovarian Cancer337
- Multiple Myeloma328
- Pancreatic Cancer287
- Gastric Cancer283
- Acute Myeloid Leukemia279
- Hepatocellular Carcinoma256
- Solid Tumor245
- Advanced Solid Tumor235
- Head and Neck Cancer225
- Cervical Cancer223
- Endometrial Cancer205
- Advanced Solid Tumors200
- Esophageal Cancer189
Leading sponsors
- M.D. Anderson Cancer Center453
- Fudan University303
- National Cancer Institute (NCI)292
- Memorial Sloan Kettering Cancer Center289
- Sun Yat-sen University273
- Mayo Clinic237
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences140
- City of Hope Medical Center140
- AstraZeneca135
- Second Affiliated Hospital, Zhejiang University, School of Medicine128
Where studies are running
- California1,406
- Texas636
- Arizona515
- Florida430
- Alabama425
- New York407
- Massachusetts340
- Maryland332
- New Jersey268
- Pennsylvania234
Recruiting studies20,120 total
- NCT04322617RecruitingPhase 2/Phase 3
Anlotinib plus immunotherapy for lung cancer after first treatment
This trial studies an oral targeted medicine (anlotinib) combined with an immunotherapy (checkpoint inhibitor) for lung cancer that did not respond to first-line chemo-immunotherapy. It may help shrink tumors and improve disease control after standard treatment has failed.
Changsha, HunanAges 18 years+ - NCT05059951Recruiting
Chemotherapy With or Without Immunotherapy for Lung Cancer
This trial looks at whether adding an immunotherapy drug (an immune checkpoint inhibitor) to chemotherapy helps people with lung cancer live better or respond better. You might be considered if your cancer is confirmed, you can tolerate treatment, and imaging shows measurable spots.
Changsha, HunanAges 18 years+ - NCT05460975Recruiting
Study of dense breast tissue seen on ultrasound
This study looks at breast cancer risk by analyzing what is seen in dense breast tissue during a screening ultrasound. It may help improve how doctors evaluate risk in people with very dense breasts.
SeoulAges 40–69 - NCT05649683Recruiting
Blood immune testing to predict melanoma response to immunotherapy
This study checks how your immune system behaves (through an immune testing process) to see if it can predict how well advanced melanoma will respond to checkpoint inhibitor treatment. It may help doctors choose the right treatment sooner, without guessing.
Nice, Alpes-maritimesAges 18 years+ - NCT06440902RecruitingPhase 2
New treatments for RAS-changed colorectal cancer using blood tests
This study tests new treatment plans for people with metastatic colorectal cancer whose tumors originally had a RAS mutation but later show no RAS mutation in blood tests. The goal is to see if these treatment changes can help shrink or control the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06440954RecruitingPhase 2
Pemetrexed injected into spinal fluid for lung cancer that spread to brain lining
This study tests a treatment called intrathecal pemetrexed, which is chemotherapy given directly into the fluid around your brain and spine. It's for people with a specific type of lung cancer that has spread to the lining of the brain or spinal cord after targeted therapy stopped working.
Changsha, HunanAges 18 years+ - NCT05248633RecruitingPhase 2
Chemo plus radiation versus radiation alone for one plasmacytoma
This Phase 2 study compares giving chemotherapy with radiation versus radiation alone for people with a single plasmacytoma (a localized plasma-cell tumor). It aims to see whether adding chemotherapy improves control of the disease while keeping side effects acceptable.
BeijingAges 18–80 - NCT07847385Recruiting
MRI-guided nerve-sparing for prostate cancer surgery
This study tests whether using special MRI scans to map nerves before surgery helps keep erectile function after prostate removal. It may help men who are having surgery for prostate cancer and want to preserve sexual function.
Geneva, Canton of GenevaAges 18 years+ - NCT07848828RecruitingPhase 4
Blood pressure and kidney study for prostate cancer treatment
This study looks at how a common prostate cancer treatment called androgen deprivation therapy (ADT) affects blood pressure and kidney function. It may help doctors understand and manage these side effects better.
Richmond, VirginiaAges 40 years+ - NCT07848243RecruitingPhase 2
A new imaging test to find returning cancer
This trial tests a new imaging agent that helps find cancer cells that have come back. It is given as an injection and then a scan is done to see if it helps doctors locate the cancer.
BeijingAges 18 years+ - NCT07847710RecruitingPhase 2
Combination therapy before and after surgery for early liver cancer
This trial is testing a combination of two drugs (one that helps the immune system fight cancer and one that blocks blood vessel growth) with a special chemotherapy given directly into the liver. The goal is to shrink the tumor so it can be removed with surgery, possibly improving the chances of a cure.
Nanjing, JiangsuAges 18–75 - NCT07849023Recruiting
Precise sphincter-saving surgery for early rectal cancer
This trial tests a refined surgical method for removing rectal tumors while preserving the anal sphincter, which may help avoid a permanent colostomy. It is for patients with early-stage rectal cancer that is close to the anus and has not spread.
Wenzhou, ZhejiangAges 18–75 - NCT07845617Recruiting
Liver pump chemotherapy for cancer that has spread to the liver
This trial tests a treatment that delivers chemotherapy directly to the liver through a small pump. It is for people whose pancreatic or duodenal cancer has spread mainly to the liver, after they have had or are still getting treatment to try to cure the cancer.
Orlando, FloridaAges 18–80 - NCT07850284Recruiting
Text message symptom check-ins for blood cancer patients
This study uses text messages to check how you're feeling during cancer treatment. It may help your care team respond sooner to symptoms and improve your quality of life.
Rochester, MinnesotaAges 18 years+ - NCT07849608Recruiting
AI Tool to Assess Tumor Response After Pre-Surgery Treatment
This study is testing an AI tool (DeepTRG) that looks at tissue samples after pre-surgery treatment to see how well the tumor responded. It may help doctors better understand whether the treatment worked.
Shijiazhuang, None SelectedAges 18 years+ - NCT07844473Recruiting
Magtrace dye to guide surgery for early breast cancer
This trial tests using a special dye called Magtrace to help surgeons find and remove the cancer and check nearby lymph nodes during breast-conserving surgery. It might help make the surgery more precise and avoid extra procedures.
MadinahAges 18 years+ - NCT07848997Recruiting
Urine test to help understand nearing end of life
This study collects urine samples from people with solid tumors to see if certain chemicals in the urine can help doctors understand how close someone is to the end of life. The goal is to improve care for patients in their final days.
Liverpool, MerseysideAges 18 years+ - NCT07842835Recruiting
Biosample registry for primary CNS lymphoma
This study collects blood, cerebrospinal fluid, and tumor tissue samples over time from people with suspected or confirmed primary central nervous system lymphoma (PCNSL) in China. The goal is to build a large biobank to better understand the disease and improve future diagnosis and treatment.
Beijing, Beijing MunicipalityAges 18–100 - NCT07847359RecruitingPhase 2
Freezing and drug combination for melanoma that has spread to the liver
This trial tests a combination of treatments for melanoma that has spread to the liver after standard treatment. It uses freezing (cryoablation), a targeted drug (lenvatinib), chemotherapy (dacarbazine), and two immunotherapy drugs to try to shrink liver tumors and control the cancer. The goal is to see if this combined approach is safe and effective for patients whose cancer has not responded to prior therapy.
Guangzhou, GuangdongAges 18–75 - NCT07844694RecruitingPhase 1
Low-dose sirolimus for patients with RUNX1 platelet disorder
This trial tests whether a low dose of sirolimus, a drug that calms the immune system, can help improve blood counts and reduce bleeding risk in people with a genetic condition called RUNX1 familial platelet disorder. If it works, it might lower the chance of developing serious blood problems later.
Portland, OregonAges 18 years+ - NCT07848815Recruiting
Lung cancer checks for COPD patients
This study looks at people with COPD to find lung cancer earlier using risk-based checks. It may help catch cancer sooner and guide better care.
Vejle, Region SyddanmarkAges 50 years+ - NCT07844941Recruiting
Personal exercise coach for breast cancer recovery
This trial uses an artificial intelligence app to create a personal exercise plan for you after your main breast cancer treatment. The goal is to help you recover and improve your health.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07847190RecruitingPhase 2
Adding paclitaxel to standard chemotherapy for tough testicular cancer
This trial tests if adding a drug called paclitaxel to the standard chemotherapy combination (BEP) can improve outcomes for people with aggressive testicular cancer. It is for those whose tumor markers did not drop as fast as expected after the first round of chemo.
MoscowAges 16 years+ - NCT07848841Recruiting
Online education for head and neck surgery patients
This study tests an online education program to help patients prepare for head and neck surgery. The program aims to improve satisfaction and recovery outcomes by providing easy-to-understand information before the operation.
St Louis, MissouriAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,120 recruiting oncology studies from the U.S. registry right now, out of 29,861 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.